AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

Study Identifier
229666-005
CT.gov Identifier
NCT02082262
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Conjunctivitis
    • Study Drug
  • AGN-229666
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    10+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Japanese patients living in Japan with allergic conjunctivitis with itching and redness * Able and willing to discontinue wearing any contact lenses during the study period.
    Exclusion Criteria:
    * Eye surgical intervention and/or a history of refractive surgery within 6 months * History of retinal detachment, diabetic retinopathy, or progressive retinal disease * Presence of active eye infection (bacterial, viral, or fungal) * History of an eye herpetic infection * Use of corticosteroids within 6 months or anticipated use during the study.

    Protocol Summary

    This study will evaluate the safety and efficacy of AGN-229666 for the treatment of seasonal or perennial allergic conjunctivitis.

    Study Locations

    Location
    Status
    Location
    Tokyo, Japan
    Status
    Not applicable